Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumescent Anesthesia Antibiotic Delivery (TAAD) and SubQKath for Prevention of Surgical Site Infection, Thrombosis and Sepsis

NCT03226626 is registered in ClinicalTrials.gov with HK Surgical, Inc. as lead sponsor.

NCT NCT03226626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumescent Anesthesia Antibiotic Delivery (TAAD) and SubQKath for Prevention of Surgical Site Infection, Thrombosis and Sepsis
Lead sponsor
HK Surgical, Inc.
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 1, 2021
Completion date
July 31, 2022
Enrollment
330 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, surgical site infection, thrombosis